Cite
HARVARD Citation
Moore, K. et al. (2021). Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). Journal of clinical oncology. 39 (17), pp. 1842-1855. [Online].